Paraventricular Nucleus Signaling Mechanisms in Hypertension

高血压的室旁核信号传导机制

基本信息

  • 批准号:
    7245319
  • 负责人:
  • 金额:
    $ 8.45万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-12-01 至 2008-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): My career goal is to have an independent research laboratory exploring the direct neuronal signaling pathways in the paraventricular nucleus (PVN) that influence hypertension. The PVN is an integrative region of the hypothalamus involved in the regulation of metabolic processes, stress responses, cardiovascular function/blood pressure regulation and the autonomic nervous system. The overall hypothesis is that sodium-dependent hypertension is associated with increased excitatory neurotransmission and hypertension that is the result of changes within the PVN. In part due to altered paracrine signaling, specifically nitric oxide (NO) and superoxide (O2-) interactions, influencing neurotransmitters. In addition, an upregulation of intracellular signaling families, phosphatidylinositol 3-kinase (PI3-kinase) and mitogen activated protein kinase (MARK), further amplifies excitatory neurotransmission resulting in hypertension. The goal is to use an integrative approach, using biochemical, gene transfer and physiological studies, to examine how both paracrine and intracellular signaling changes in the PVN to increase excitatory sympatho-adrenal function and elevate blood pressure. To achieve this goal 4 hypotheses will be addressed (2 during the mentored period and 2 during the independent portion of the grant): Hypothesis #1: NAD(P)H oxidase is present in the PVN and its activity is increased by Ang II and glutamate, thus elevating O2- levels in renal wrap hypertension. Hypothesis #2: In renal wrap hypertension, there is elevated O2- which combines with NO, reducing bioavailable NO and ultimately increasing sympathoadrenal function and blood pressure. Hypothesis #3: Ang II via the AT1 receptor and Glutamate via the NMDA receptor utilize common signaling pathways involving an upregulated PI3-kinase signaling cascade, increasing O2-, in turn, elevating excitatory neurotransmission in hypertension. Hypothesis #4: Enhanced O2- levels act as signaling molecules that lead to the activation of the MAPK signaling cascade in the PVN, ultimately elevating excitatory neurotransmission in hypertension. Identifying the changes in paracrine and intracellular signaling pathways is significantly important for understanding the impact signaling pathways have on neurotransmitter activity and hypertension. In addition, due to the integrative nature of the PVN, these data will also provide a glimpse at the role of signaling in other physiological conditions, such as obesity. (End of Abstract)
描述(由申请人提供): 我的职业目标是拥有一个独立的研究实验室,探索直接神经元信号 影响高血压的室旁核(PVN)通路。室旁核是下丘脑的一个综合区,参与新陈代谢过程、应激反应、心血管功能/血压调节和自主神经系统的调节。总体假设是钠依赖型高血压与兴奋性神经传递增加有关,而高血压是室旁核变化的结果。部分原因是旁分泌信号的改变,特别是一氧化氮(NO)和超氧阴离子(O2-)的相互作用,影响了神经递质。此外,细胞内信号家族磷脂酰肌醇的上调 3-激酶(PI3-激酶)和丝裂原活化蛋白激酶(MARK),进一步放大兴奋性神经传递,导致高血压。我们的目标是使用一种综合的方法,利用生化、基因转移和生理学研究,研究PVN中的旁分泌和细胞内信号如何改变以增加兴奋性交感-肾上腺功能和升高血压。为了实现这一目标,将提出4个假设(2个在指导期间,2个在赠款的独立部分):假设1:PVN中存在NAD(P)H氧化酶,其活性因Ang II和谷氨酸而增加,从而提高肾包膜高血压患者的O2-水平。假设2:肾包膜高血压患者体内O2-与NO结合,降低了生物可利用的NO,最终增加了交感肾上腺功能和血压。假设3:Ang II通过AT1受体,谷氨酸通过NMDA受体,利用共同的信号通路,包括上调的PI3-激酶信号级联,增加O2-,进而提高高血压的兴奋性神经传递。假设4:增强的O2-水平起信号分子的作用,导致PVN中MAPK信号级联激活,最终提高高血压患者的兴奋性神经传递。确定旁分泌和细胞内信号通路的变化对于了解信号通路对神经递质活性和高血压的影响具有重要意义。此外,由于PVN的综合性,这些数据还将提供信号在其他生理状况中的作用,如肥胖。(摘要结束)

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CARRIE A NORTHCOTT其他文献

CARRIE A NORTHCOTT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CARRIE A NORTHCOTT', 18)}}的其他基金

Paraventricular Nucleus Signaling Mechanisms in Hypertension
高血压的室旁核信号传导机制
  • 批准号:
    7632355
  • 财政年份:
    2008
  • 资助金额:
    $ 8.45万
  • 项目类别:
Paraventricular Nucleus Signaling Mechanisms in Hypertension
高血压的室旁核信号传导机制
  • 批准号:
    7691736
  • 财政年份:
    2008
  • 资助金额:
    $ 8.45万
  • 项目类别:
Paraventricular Nucleus Signaling Mechanisms in Hypertension
高血压的室旁核信号传导机制
  • 批准号:
    7904956
  • 财政年份:
    2008
  • 资助金额:
    $ 8.45万
  • 项目类别:
ROS and NO interaction in the PVN during hypertension?
高血压期间 PVN 中 ROS 和 NO 相互作用?
  • 批准号:
    7057176
  • 财政年份:
    2006
  • 资助金额:
    $ 8.45万
  • 项目类别:
Paraventricular Nucleus Signaling Mechanisms in Hypertension
高血压的室旁核信号传导机制
  • 批准号:
    7323258
  • 财政年份:
    2006
  • 资助金额:
    $ 8.45万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 8.45万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 8.45万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.45万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.45万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 8.45万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.45万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 8.45万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 8.45万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 8.45万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.45万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了